Related Experiment Videos
Microsatellite instability in hematological malignancies.
Lenka Krsková-Honzátková1, Jaroslav Cermák, Jana Sajdová
1Institute of Hematology and Blood Transfusion, Prague, Czech Republic. lenka.krskova@lfmotol.cuni.cz
Leukemia & Lymphoma
|December 17, 2002
Summary
Microsatellite instability (MSI), a replication error (RER+) phenotype, was investigated in hematological malignancies. MSI was found in a subset of patients, suggesting its potential role in these cancers.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- The replication error (RER+) phenotype is characterized by microsatellite instability (MSI).
- MSI is linked to DNA mismatch repair gene mutations, initially identified in hereditary non-polyposis colorectal cancer (HNPCC).
Purpose of the Study:
- To investigate the presence and potential role of MSI in hematological malignancies.
- To determine the frequency of the RER+ phenotype in patients with various blood cancers.
Main Methods:
- Analysis of 44 patients with hematological malignancies, including acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), chronic myeloid leukemia in blast phase (CML-BP), and T-acute lymphoblastic leukemia (T-ALL).
- Assessment for evidence of microsatellite instability (MSI) across multiple markers.
Main Results:
- Twenty-seven percent of patients exhibited instability in a single marker.
- Four cases (9.1%) displayed MSI in multiple markers, consistent with the RER+ phenotype.
- The RER+ phenotype was identified in a subset of patients with hematological malignancies.
Conclusions:
- Microsatellite instability (MSI) and the replication error (RER+) phenotype may be relevant in a subset of hematological malignancies.
- Further research is warranted to elucidate the role of DNA mismatch repair pathways in blood cancers.